Case study · Meridian
Meridian took the slow road through the public health system and won
Three years of clinical validation looked like stagnation. It was actually the moat.
Meridian spent its first three years doing something most investors dislike: running clinical validation studies inside public hospitals with almost no revenue to show for it.
The company's triage model needed to demonstrate a measurable outcome improvement before any health service would deploy it beyond a pilot ward. There was no way to shortcut that work.
What the slow road bought was a body of peer-reviewed evidence that competitors cannot replicate without repeating the same three years. When statewide procurement opened, Meridian was the only vendor with the data to answer it.
The company now operates across the majority of the state's emergency departments, and the evidence base has become the core of its international expansion pitch.
It is a useful counterweight to the speed narrative. In regulated markets, the boring work is the defensibility.